DUBLIN--(BUSINESS WIRE)--The "Meningococcal Vaccines Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global meningococcal vaccines market to grow with a healthy CAGR over the forecast period from 2019-2025.
The report on the global meningococcal vaccines market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on meningococcal vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.
The report on meningococcal vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global meningococcal vaccines market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global meningococcal vaccines market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
- The rising prevalence of meningococcal diseases
- The increasing government initiative to create awareness about meningococcal diseases
- The stringent regulatory framework for vaccine approval
- Research and development happening to innovate and produce new vaccines
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the meningococcal vaccines market.
2. Complete coverage of all the segments in the meningococcal vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global meningococcal vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Key Topics Covered
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Meningococcal Vaccines Market Highlights
2.2. Meningococcal Vaccines Market Projection
2.3. Meningococcal Vaccines Market Regional Highlights
3. Global Meningococcal Vaccines Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by End-use
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Meningococcal Vaccines Market
4. Meningococcal Vaccines Market Macro Indicator Analysis
5. Global Meningococcal Vaccines Market by Type
5.1. Polysaccharide Vaccines
5.2. Conjugate Vaccines
5.3. Combination Vaccines
5.4. Men B Vaccines
6. Global Meningococcal Vaccines Market by End-use
6.3. Retail Pharmacies
6.4. Other End-use
7. Global Meningococcal Vaccines Market by Region
7.1. North America
7.1.1. North America Meningococcal Vaccines Market by Type
7.1.2. North America Meningococcal Vaccines Market by End-use
7.1.3. North America Meningococcal Vaccines Market by Country
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Meningococcal Vaccines Market
8.2. Companies Profiled
8.2.1. Bayer AG
8.2.2. GlaxoSmithKline plc
8.2.3. Pfizer Inc.
8.2.4. Nuron Biotech Inc.
8.2.5. Baxter International Inc.
8.2.6. Biomed Pvt. Ltd.
8.2.7. Serum Institute of India Pvt. Ltd.
8.2.8. Sanofi Pasteur Inc.
8.2.9. JN-International Medical Corporation
8.2.10. Merck & Co. Inc.
For more information about this report visit https://www.researchandmarkets.com/r/23dkff